. Author manuscript; available in PMC: 2011 Sep 13.

Published in final edited form as: Res Eval. 2009 Dec;18(5):375–385. doi: 10.3152/095820209X480698

Table 3.

Research Dissemination Mechanisms by NIEHS Funding, Clinical Background, and Research Type

	Respondent Characteristics (% respondents)
	All	NIEHS		Clinical		Research Type
Dissemination mechanism	N=725	Ever N=192	Never N=422	Yes N=353	No N=334	Basic N=266	Applied N=276	Both N=162
Published in peer-reviewed journals	94.5	95.8	93.6	96.0	94.8	96.1	92.6	95.6
Presented at scientific conferences	93.5	95.3	91.7	94.8	92.9	93.1	93.4	96.3
Participated in grantee meetings	51.6	66.8^*	47.2	57.2^*	44.3	39.4^a	55.7^b	64.4^c
Participated in workshops or trainings disseminating your research	46.9	57.4^*	44.7	49.7	42.8	33.2^a	53.5^b	57.5^b
Provided information for press releases	30.9	45.8^*	27.9	34.5^*	24.9	15.1^a	39.1^b	42.5^c
Developed and disseminated research tools and methods	28.7	38.4^*	25.9	28.2	30.0	20.1^a	33.2^b	36.3^b
Presented research in community forums	26.7	44.7^*	19.8	29.6^*	22.2	12.7^a	36.9^b	31.3^c
Developed and disseminated curricula	26.0	36.3^*	23.2	29.3^*	21.5	18.5^a	32.5^b	27.5^c
Developed and disseminated interventions	16.2	21.1^*	14.4	19.8^*	10.5	3.5^a	28.8^b	15.6^c
Developed fact sheets and pamphlets	14.9	24.2^*	12.7	16.7^*	9.5	2.3^a	28.8^b	11.9^c
Developed and published websites	12.8	17.9^*	11.3	12.1	13.3	5.8^a	18.5^b	14.4^c
Participated in the development of clinical guidelines for the treatment of asthma	12.0	13.2	12.7	21.3^*	2.5	2.7^a	21.4^b	11.3^c
Provided scientific testimony and briefings to legislators	9.7	19.0^*	6.9	12.4^*	5.2	5.4^a	13.3^b	11.3^b

The percentage differences are statistically significant (chi-square test, p<.05)

For three-way comparisons, estimates with different lowercase superscripts are significantly different and estimates with the same letter superscript are not significantly different from each other (Tukey–Kramer test, p<.05)